SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-23-068959
Filing Date
2023-06-07
Accepted
2023-06-07 17:06:14
Documents
5
Effectiveness Date
2023-06-07

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2317965d1_s8.htm S-8 70176
2 EXHIBIT 5.1 tm2317965d1_ex5-1.htm EX-5.1 8121
3 EXHIBIT 23.2 tm2317965d1_ex23-2.htm EX-23.2 2444
4 EX-FILING FEES tm2317965d1_ex-filingfees.htm EX-FILING FEES 11850
5 GRAPHIC tm2317965d1_ex5-1img01.jpg GRAPHIC 1942
  Complete submission text file 0001104659-23-068959.txt   96535
Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Filer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-272500 | Film No.: 23999757
SIC: 2834 Pharmaceutical Preparations